KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Sales (2016 - 2025)

Historic Return on Sales for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.22%.

  • Emergent BioSolutions' Return on Sales fell 1700.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year increase of 3200.0%. This contributed to the annual value of 0.18% for FY2024, which is 5400.0% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Return on Sales of 0.22% as of Q3 2025, which was down 1700.0% from 0.09% recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Return on Sales registered a high of 0.39% during Q3 2024, and its lowest value of 5.66% during Q2 2024.
  • In the last 5 years, Emergent BioSolutions' Return on Sales had a median value of 0.11% in 2021 and averaged 0.45%.
  • Its Return on Sales has fluctuated over the past 5 years, first tumbled by -48900bps in 2024, then soared by 55800bps in 2025.
  • Emergent BioSolutions' Return on Sales (Quarter) stood at 0.24% in 2021, then tumbled by -184bps to 0.2% in 2022, then rose by 12bps to 0.18% in 2023, then rose by 10bps to 0.16% in 2024, then surged by 238bps to 0.22% in 2025.
  • Its Return on Sales stands at 0.22% for Q3 2025, versus 0.09% for Q2 2025 and 0.31% for Q1 2025.